NORWALK, Conn.–(BUSINESS WIRE)–Xerox Holdings Corporation (NASDAQ: XRX) announced today its participation at the upcoming Morgan Stanley Technology, Media & Teleconference at 8 a.m. PST on March 10, 2022 at The Palace Hotel in San Francisco.
|
Morgan Stanley Technology, Media & Teleconference |
||||
|
WHEN: |
8 a.m.- 5:15 p.m. PST, Thursday, March 10, 2022 | |||
|
WHAT: |
Xerox at the Morgan Stanley Technology, Media & Teleconference | |||
|
WHO: |
Xavier Heiss, chief financial officer, Xerox Louie Pastor, executive vice president and chief corporate development officer and chief legal officer, Xerox David Beckel, vice president and head of investor relations, Xerox |
|||
|
|
|
|||
|
WEBCAST: |
https://cc.webcasts.com/morg007/030722a_js/?entity=139_POQOG62 |
|||
|
|
Replay available. | |||
About Xerox
For more than 100 years, Xerox has continually redefined the workplace experience. Harnessing our leadership position in office and production print technology, we’ve expanded into software and services to sustainably power today’s workforce. From the office to industrial environments, our differentiated business solutions and financial services are designed to make every day work better for clients — no matter where that work is being done. Today, Xerox scientists and engineers are continuing our legacy of innovation with disruptive technologies in digital transformation, augmented reality, robotic process automation, additive manufacturing, Industrial Internet of Things and cleantech. Learn more at xerox.com.
Note: To receive RSS news feeds, visit https://www.news.xerox.com.
For open commentary, industry perspectives and views, visit http://www.linkedin.com/company/xerox, http://twitter.com/xerox, http://www.facebook.com/XeroxCorp, https://www.instagram.com/xerox/, http://www.youtube.com/XeroxCorp.
Xerox® is a trademark of Xerox Corporation in the United States and/or other countries.
Contacts
Investor Contact:
David Beckel, Xerox, +1-203-849-2318, David.Beckel@xerox.com
Media Contact:
Justin Capella, Xerox, +1-203-258-6535, Justin.Capella@xerox.com
GUELPH, ON / ACCESS Newswire / March 4, 2026 / Zentek Ltd. ("Zentek" or the…
80% year-over-year increase in human antibody drug candidates, with the two most advanced now in…
Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following…
Firm Commits Up to $15,000 to Double Community Donations Across Seven Counties PITTSBURGH, PENNSYLVANIA /…
Nikon is Bringing its Innovative Energy to Austin, Inviting Creatives to Dive into Hands-on Photo…
GridAI software platform to orchestrate power across Amp Z's Planned Portfolio of 5GW+ of AI…
